Showing results (61-70 of 604) with videos related to

Sort By:
Pageof 61
Clinical and Experimental Rheumatology|June 6, 2023
Relevance of inflammatory and complement activation biomarkers profiling in antiphospholipid syndrome patients outside acute thrombosisCecile M Yelnik, Marc Lambert, Elodie Drumez, et al.
Presse Medicale (Paris, France : 1983)|January 14, 2010
[Neuropsychiatric manifestations in systemic sclerosis]David Launay, Thierry Baubet, Olivier Cottencin, et al.
Presse Medicale (Paris, France : 1983)|December 24, 2014
[Angioedema: differential diagnosis]David Launay
Frontiers in Immunology|July 19, 2019
Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature ReviewAmélie Leurs, Viviane Gnemmi, Arnaud Lionet, et al.
BMC Nephrology|November 11, 2018
Early predictors of one-year mortality in patients over 65 presenting with ANCA-associated renal vasculitis: a retrospective, multicentre studyDimitri Titeca-Beauport, Alexis Francois, Thierry Lobbedez, et al.
Clinical Rheumatology|February 4, 2014
Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximabMarion Heusele, Pierre Clerson, Benoit Guery, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2019
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic SclerosisVincent Sobanski, Jonathan Giovannelli, Yannick Allanore, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 23, 2010
Comparison of the Farr radioimmunoassay, 3 commercial enzyme immunoassays and Crithidia luciliae immunofluorescence test for diagnosis and activity assessment of systemic lupus erythematosusDavid Launay, Jean Schmidt, Sébastien Lepers, et al.
Rheumatology (Oxford, England)|February 11, 2010
Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcomeEric Hachulla, David Launay, Azzedine Yaici, et al.
Proteomics|October 19, 2021
Passages in culture and stimulation conditions influence protein expression of primary fibroblastsSolange Vivier, Aurélien Chepy, Fabrice Bray, et al.
Pageof 61